TD Waterhouse Canada Inc. Sells 81,243 Shares of CVS Health Corporation $CVS

TD Waterhouse Canada Inc. decreased its stake in CVS Health Corporation (NYSE:CVS) by 19.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 328,360 shares of the pharmacy operator’s stock after selling 81,243 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in CVS Health were worth $22,842,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of CVS. Avion Wealth raised its holdings in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc lifted its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Roxbury Financial LLC increased its position in CVS Health by 78.3% during the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after buying an additional 202 shares during the last quarter. Finally, ORG Partners LLC raised its stake in CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 377 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on CVS shares. Mizuho increased their price target on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Jefferies Financial Group upped their price target on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Wall Street Zen cut CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Cowen reissued a “buy” rating on shares of CVS Health in a report on Monday, August 4th. Finally, Morgan Stanley increased their price objective on CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 14th. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $89.41.

CVS Health Stock Down 0.1%

Shares of NYSE CVS opened at $77.86 on Wednesday. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15. The stock’s fifty day moving average is $77.98 and its 200 day moving average is $70.09. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The stock has a market capitalization of $98.84 billion, a P/E ratio of 204.79, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the firm earned $1.09 EPS. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is 700.00%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.